Dermatomyositis: Diagnosis and treatment
- PMID: 31279813
- DOI: 10.1016/j.jaad.2019.05.105
Dermatomyositis: Diagnosis and treatment
Abstract
The second article in this continuing medical education series reviews the initial evaluation of patients with suspected dermatomyositis (DM), the relevant work-up for malignancy and interstitial lung disease once a diagnosis of DM is made, and treatment recommendations for patients with DM based on disease severity, the presence of systemic symptoms, and myositis-specific antibody (MSA) profiles. This review emphasizes the emerging role of MSAs in the diagnosis of DM and highlights how MSAs can be used to guide the appropriate work-up for malignancy and interstitial lung disease. The treatment approach proposed by this continuing medical education series discusses both established and novel therapies for DM and highlights the importance of considering lesion type, degree of muscle involvement, presence of systemic symptoms, presence of MSAs, and patient age when determining the best treatment approach for a patient with DM.
Keywords: anti-MDA5 dermatomyositis; cancer-associated dermatomyositis; dermatomyositis; juvenile dermatomyositis.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Dermatomyositis: Clinical features and pathogenesis.J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279808 Review.
-
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2. Respir Med. 2016. PMID: 27888997
-
[Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].Zhonghua Jie He He Hu Xi Za Zhi. 2019 Oct 12;42(10):765-770. doi: 10.3760/cma.j.issn.1001-0939.2019.10.010. Zhonghua Jie He He Hu Xi Za Zhi. 2019. PMID: 31594111 Chinese.
-
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16546580 Review.
-
Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.J Neurol Sci. 2019 Feb 15;397:123-128. doi: 10.1016/j.jns.2018.12.040. Epub 2018 Dec 31. J Neurol Sci. 2019. PMID: 30616054
Cited by
-
Dermatomyositis: Practical Guidance and Unmet Needs.Immunotargets Ther. 2024 Mar 6;13:151-172. doi: 10.2147/ITT.S381472. eCollection 2024. Immunotargets Ther. 2024. PMID: 38464459 Free PMC article. Review.
-
Concurrence of dermatomyositis and psoriasis: a case report and literature review.Front Immunol. 2024 Jan 29;15:1345646. doi: 10.3389/fimmu.2024.1345646. eCollection 2024. Front Immunol. 2024. PMID: 38348029 Free PMC article. Review.
-
Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin.JAAD Case Rep. 2023 Nov 30;45:1-3. doi: 10.1016/j.jdcr.2023.11.006. eCollection 2024 Mar. JAAD Case Rep. 2023. PMID: 38333680 Free PMC article. No abstract available.
-
A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers.Int Med Case Rep J. 2024 Jan 6;17:9-15. doi: 10.2147/IMCRJ.S441691. eCollection 2024. Int Med Case Rep J. 2024. PMID: 38205150 Free PMC article.
-
Adverse cutaneous reaction to hydroxychloroquine in a patient with anti-SAE-1-positive dermatomyositis and a history of diffuse large B-cell lymphoma.Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):158-161. doi: 10.1080/08998280.2023.2274231. eCollection 2024. Proc (Bayl Univ Med Cent). 2023. PMID: 38174019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
